Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Atria Plc: SHARE REPURCHASE 29.3.2023

Atria Plc  ANNOUNCEMENT  29.3.2023 Atria Plc: SHARE REPURCHASE 29.3.2023 In the Helsinki Stock Exchange Trade date           29.3.2023Bourse trade         BuyShare                  ATRAVAmount             1 000 SharesAverage price/ share    11,3900 EURTotal cost            11 390,00 EUR Atria Plc now holds a total of 14 502 sharesincluding the shares repurchased on 29.3.2023 On behalf of Atria Plc Nordea Bank Oyj Janne Sarvikivi           Sami

Offshore Wind A.I Business – Nottingham Based Cognitive – Appointed to Provide Full Service A.I. and Forecasting Package to RWE’S Robin Rigg Windfarm

One of the UK’s leading machine learning and applied A.I. innovators - operating in the energy space and supporting owner operators with the planning of data driven and accurate maintenance programmes- has announced it has been appointed to provide a complete package of A.I and forecasting to RWE’s Robin Rigg Wind Farm.One of the UK’s leading machine learning and applied A.I. innovators - operating in the energy space and supporting owner operators with the planning of data driven and accurate maintenance programmes- has announced it has been appointed to provide a complete package of A.I

Tracerco Announces Launch of Next Generation Personal Electronic Dosimeter Range – PED2 – Set to Revolutionise the Management of Radiation Safety

One of the world’s leading providers of radiation monitoring equipment – Tracerco - has announced the launch of its range of next generation personal electronic dosimeters that will provide clients with a patented detection technology to enhance radiological safety performance.The PED2 range of dosimeters – which is the latest iteration of Tracerco’s already successful personal electronic dosimeter (PED) range - will enable clients to effectively monitor, measure and manage radiation exposure.  Providing a grab-and-go radiation dosimetry solution, Tracerco’s unique PED2 technology will

Everfuel: Appointment of interim CFO

Herning, Denmark, 29 March 2023 – Everfuel A/S has appointed deputy CEO Martin Skov Hansen as interim CFO effective from today. The current CFO, Anders Bertelsen, will at the same time step down to pursue opportunities outside of the Company. “I am very grateful for my time at Everfuel. It has been truly exciting and rewarding, on both a personal and professional level, to have taken part in the Everfuel growth journey together with the entire team of Everfuellers,” said Anders Bertelsen. “It has been a pleasure working with Anders and I would like to thank him for his dedication and

Supplement to the notice convening the Annual General Meeting of PostNord AB (publ), to be held at PostNord’s head quarter at 4 pm on April 25, 2023

Note: Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.  The notice convening the 2023 Annual General Meeting, which was published on March 22, 2023, is hereby supplemented as follows. Under the heading Proposed Resolutions, item 2 (Election of the Chairman of the AGM) and item 13 (Report on the shareholders’ proposal for a resolution on fees, number of directors, directors, Board Chairman and Board Vice-Chairman), shall be supplemented with the consequence that they have the

Belarusian Local Court Ruled on a Fine of 11,6 Million Euro for Lidskoe Pivo

Olvi plc             Inside information 29 March 2023 at 6.00 pm. Belarusian Local Court Ruled on a Fine of 11,6 Million Euro for Lidskoe Pivo The Court of Leninskiy district of Minsk city court has rejected the appeal made by Olvi´s subsidiary Lidskoe Pivo regarding the fine set by The State Control Committee of the Republic of Belarus and ordered Lidskoe Pivo to pay a fine of 35,8 million Belarusian ruble (11,6 million euro*). Olvi announced on February 20. 2023 about the fine based on the Committee inspection and Lidskoe Pivo´s court appeal regarding the fine. Lidskoe Pivo will

#23-107 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#23-106 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Resolutions by Fabege’s Annual General Meeting on 29 March 2023

At Fabege AB’s Annual General Meeting on 29 March 2023, the meeting fixed the Board’s dividend proposal for 2022 at SEK 2.40 per share, to be paid on four occasions (SEK 0.60 per share on each occasion). Furthermore, it was decided that the record date for receiving the dividend will be 31 March 2023, 30 June 2023, 2 October 2023 and 8 January 2024, which means that payment is expected to be issued by Euroclear Sweden AB on on 5 April 2023, 5 July 2023, 5 October 2023 and on 11 January 2024.The Annual General Meeting decided to re-election of Board members Anette Asklin, Mattias Johansson,

ChromoGenics announces the outcome of exercised warrants of series TO 4 and TO 5

PRESS RELEASE THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE SUCH ACTION IN WHOLE OR IN PART IS SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN CHROMOGENICS AB (PUBL). SEE ALSO THE “IMPORTANT INFORMATION” SECTION BELOW.The board of directors of ChromoGenics AB ("ChromoGenics" or the "Company") today announces the outcome of the exercise period

Management Changes at BioGaia AB

Isabelle Ducellier, Chief Executive Officer has today announced that she has decided to resign from the company and take on the role as Chief Executive Officer of Orkla portfolio company Orkla Health. Isabelle Ducellier will remain in her role until September 30, 2023. Isabelle Ducellier was appointed as Chief Executive Officer and President effective November 5, 2018 and was before this elected to the BioGaia Board earlier in 2018. “I am very grateful for these 5 years spent leading BioGaia’s transformation journey into a leading consumer centric probiotic company. I have no doubt

Salmon Evolution ASA – Signed agreement for new NOK 1,550 million green debt financing package

Salmon Evolution ASA ("Salmon Evolution" or the "Company", OSE: SALME) is pleased to announce that it has entered into a binding loan agreement with DNB and Nordea (the “Lenders”) for a new green debt financing package totalling NOK 1,550 million relating to phase 1 and 2 at Indre Harøy. The new debt financing package consists of the following facilities: · NOK 525 million non-amortizing Term Loan Facility which will refinance the Company’s existing NOK 525 million construction loan relating to phase 1 (the “Term Loan”) · NOK 250 million RCF Capex Facility available for general

Konecranes Plc: Board of Directors’ organizing meeting

KONECRANES PLC STOCK EXCHANGE RELEASE March 29, 2023 at 5:30 pm EEST   Konecranes Plc: Board of Directors’ organizing meeting   Konecranes’ Board of Directors elected in today’s Annual General Meeting has held its first meeting.   Christoph Vitzthum was elected as Chair of the Board and Pasi Laine was elected as Vice Chair of the Board in the Annual General Meeting.   The Board of Directors decided to continue with an Audit Committee and a Human Resources Committee.   Ulf Liljedahl was elected Chair of the Audit Committee, and Niko Mokkila, Gun Nilsson and

Sassenus Packaging becomes part of Lagercrantz Group

Asept International AB, part of Lagercrantz Niche Products Division, has through its subsidiary Hovicon International B.V. acquired the assets of Sassenus Packaging, a distributor of dispensers, taps and triggers sprayers to the chemical industry in Europe. Sassenus is based outside Amsterdam in the Netherlands. The business generates an annual revenue of around MEUR 1.3 with good profitability. For more information, please visit www.hovicon.com.“Sassenus has been one of our most important business partners since 1999. It is very natural that we now join our forces when the previous owner

SaltX Annual Report for 2022 has been published

Today, SaltX Technology Holding AB (publ) publishes its annual report with an accompanying corporate governance report that describes the 2022 operations. The report can be downloaded here: https://investor.saltxtechnology.com/investor/financial-reports/The corporate governance report can be downloaded here .For more information, please contact:Carl-Johan Linér, CEO, +46 70 532 08 08Harald Bauer, CFO, +46 70 810 80 34 About SaltX:SaltX Technology is a Swedish Greentech

The Land and Environment Court announces date of decision on Cinis Fertilizer’s environmental permit application

The Land and Environment Court has today announced that the decision in the case regarding Cinis Fertilizer’s environmental permit application for the production facility in Örnsköldsvik will be published on May 5, 2023.Cinis Fertilizer has applied for an environmental permit for the company’s planned production facility for mineral fertilizer in Köpmanholmen, south of Örnsköldsvik. Today, the Land and Environment Court in Umeå (Sw. Mark- och miljödomstolen) concluded its main hearing, which partly took place on site in Köpmanholmen on March 28–29. During the negotiations, no new claims

Essity’s 2023 Annual General Meeting

Essity today held the Annual General Meeting at Stockholm Waterfront Congress Centre, Sweden.The Meeting approved the Parent Company income statement and balance sheet and the consolidated income statement and consolidated balance sheet for 2022. The Meeting resolved in accordance with the Board of Director’s proposal and decided on a dividend of SEK 7.25 per share for the 2022 fiscal year. Record date for the dividend is set to Friday, March 31, 2023. The dividend is scheduled to be distributed by Euroclear Sweden AB on Wednesday, April 5, 2023. The Meeting resolved that the

Prostatype Genomics enters collaboration with Spanish Eurofins Megalab

Prostatype Genomics begins collaboration with Eurofins Megalab, leader in clinical analysis on the Spanish laboratory market and part of Eurofins, one of the world's largest laboratory groups present in Europe, USA, Asia, and Latin America. The agreement means that Eurofins Megalab will manage all steps in the laboratory process required to analyze the Prostatype® test on the Spanish and Portuguese markets. The collaboration is another step in Prostatype Genomics' work to further accelerate commercialization in Europe. The agreement will enter into force immediately.Prostatype Genomics

Raute Corporation - Managers' transactions - Myyryläinen Jari

RAUTE CORPORATION MANAGERS’ TRANSACTIONS 29 MARCH 2023 at 4:35 p.m.RAUTE CORPORATION - MANAGERS’ TRANSACTIONS – MYYRYLÄINEN JARI____________________________________________ Person subject to the notification requirement Name: Jari Antero Myyryläinen Position: Other senior manager Issuer: Raute Oyj LEI: 743700G00629V99PE435 Notification type: INITIAL NOTIFICATION Reference number: 28090/9/6 ____________________________________________ Transaction date: 2023-03-28 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009004741 Nature of

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc         Managers’ transactions       29 March 2023 at 4:30 p.m. Pihlajalinna Plc: Managers’ transactions Pihlajalinna Plc has received the following notification on 28 March 2023: Person subject to the notification requirement Name: Timo Harju Position: Other senior manager   Issuer: Pihlajalinna Oyj LEI: 74370058MTRLEDOCHV67   Notification type: INITIAL NOTIFICATION Reference number: 28052/5/4 ____________________________________________ Transaction date: 2023-03-28 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE

Best Casino Bonuses in New Zealand: Your Guide to Winning Big

Discover the Top Casino Bonuses in New Zealand: A Comprehensive Guide for GamblersThe demand for casino bonuses in New Zealand has doubled in recent years, which clearly shows that more and more Kiwis are looking for good casino bonuses and not just a good online casino. But online casinos can be a bit confusing if you look at the 100s of gaming sites available and all of them have different bonuses. [Casino bonus school] What exactly is a good bonus? What types of bonuses are offered and how do you choose the best one? We want to help more players get answers to this in this

Hansa Biopharma announces positive reimbursement decision in Spain for Idefirix[®] (imlifidase) as desensitization treatment for highly sensitized patients in kidney transplantation

Lund, Sweden, March 29, 2023. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced that the Spanish Minister of Health (Ministerio de Sanidad) has granted access and reimbursement to Idefirix[®], the company’s first-in-class treatment, for the desensitization of highly sensitized adult patients prior to kidney transplant from a deceased donor. The positive reimbursement decision follows the conditional approval granted by EMA in August 2020.[1] Søren Tulstrup, President and CEO, Hansa Biopharma said, “At

Notice to attend the Annual General Meeting of AddLife AB (publ)

The shareholders of AddLife AB (publ) (the “Company”), reg. no 556995-8126, are hereby given notice to attend the Annual General Meeting to be held at 4:00 p.m. CEST, Thursday, 4 May 2023, at World Trade Center, room New York, Klarabergsviadukten 70, Stockholm, Sweden. Registration for the meeting commences at 3:30 p.m. CEST.   NOTICE OF PARTICIPATION Shareholders who wish to participate in the proceedings of the Annual General Meeting must: · be entered in the shareholders’ register kept on behalf of the Company by Euroclear Sweden AB as of the record date, Tuesday 25 April

Acapela Group announces my-own-voice 4 to enable easy creation of personalized AI-based synthetic voices

Acapela Group , an independent and fully-owned subsidiary of Tobii Dynavox , today announced version 4 of its AI-based solution my-own-voice, making it even easier to create a high-quality personalized synthetic voice for individuals with voice impairments. The new version will be available later this year. my-own-voice 4 is a web-based solution, developed to easily create a personalized synthetic voice, based on either existing recordings (message banking) or the user’s own voice recordings (voice banking.) It is primarily

There are no items matching the current filter
There are no more items matching the current filter
Back to top